Dr. Paul Offit

I mean, here's a virus that had unusual biological characteristics, unusual clinical characteristics that was met with the technology, messenger RNA, which we had no previous experience with, none. And yet it was a very safe and very effective vaccine. I think it was the greatest accomplishment of the Trump administration. So the question is, why, if anything, does he distance himself from that?

I mean, here's a virus that had unusual biological characteristics, unusual clinical characteristics that was met with the technology, messenger RNA, which we had no previous experience with, none. And yet it was a very safe and very effective vaccine. I think it was the greatest accomplishment of the Trump administration. So the question is, why, if anything, does he distance himself from that?

I mean, here's a virus that had unusual biological characteristics, unusual clinical characteristics that was met with the technology, messenger RNA, which we had no previous experience with, none. And yet it was a very safe and very effective vaccine. I think it was the greatest accomplishment of the Trump administration. So the question is, why, if anything, does he distance himself from that?

And I think it's because of his heart. He's a very modest man who doesn't like to put his name on things. Yeah. but I could be wrong about that.

And I think it's because of his heart. He's a very modest man who doesn't like to put his name on things. Yeah. but I could be wrong about that.

And I think it's because of his heart. He's a very modest man who doesn't like to put his name on things. Yeah. but I could be wrong about that.

Well, certainly, I mean, so this year's Nobel Prize winners were Katie Carrico and Drew Weissman, University of Pennsylvania. I've actually known Drew for a while. They met at a copying machine. Ask your parents about it. It's where you physically could copy a piece of paper. But in 1997, and that's when they started their effort to do this. So you're right.

Well, certainly, I mean, so this year's Nobel Prize winners were Katie Carrico and Drew Weissman, University of Pennsylvania. I've actually known Drew for a while. They met at a copying machine. Ask your parents about it. It's where you physically could copy a piece of paper. But in 1997, and that's when they started their effort to do this. So you're right.

Well, certainly, I mean, so this year's Nobel Prize winners were Katie Carrico and Drew Weissman, University of Pennsylvania. I've actually known Drew for a while. They met at a copying machine. Ask your parents about it. It's where you physically could copy a piece of paper. But in 1997, and that's when they started their effort to do this. So you're right.

I mean, this isn't something that just happened. And so mRNA has been around for a long time. Actually, the original studies... that were done like in the late 1980s, where you showed that you could take messenger RNA, inject it into a mouse muscle, and that the muscle would take up the messenger RNA and make a protein.

I mean, this isn't something that just happened. And so mRNA has been around for a long time. Actually, the original studies... that were done like in the late 1980s, where you showed that you could take messenger RNA, inject it into a mouse muscle, and that the muscle would take up the messenger RNA and make a protein.

I mean, this isn't something that just happened. And so mRNA has been around for a long time. Actually, the original studies... that were done like in the late 1980s, where you showed that you could take messenger RNA, inject it into a mouse muscle, and that the muscle would take up the messenger RNA and make a protein.

That was Robert Malone did those studies in 1980, who has since become a virulent anti-vaccine activist, which is sad. So yeah, I think that it's been... an amazing story, and you're right. It's not when people say the technology was too new. It certainly was novel technology for a vaccine, but the technology itself wasn't new.

That was Robert Malone did those studies in 1980, who has since become a virulent anti-vaccine activist, which is sad. So yeah, I think that it's been... an amazing story, and you're right. It's not when people say the technology was too new. It certainly was novel technology for a vaccine, but the technology itself wasn't new.

That was Robert Malone did those studies in 1980, who has since become a virulent anti-vaccine activist, which is sad. So yeah, I think that it's been... an amazing story, and you're right. It's not when people say the technology was too new. It certainly was novel technology for a vaccine, but the technology itself wasn't new.

And I think that the size of those trials, 30,000 to 40,000 people, that's atypical pediatric or adult vaccine trial. So it wasn't, it was, the reason it happened so quickly was that the government took the risk out of it for the companies. I mean, we made a rotavirus vaccine in 26 years.

And I think that the size of those trials, 30,000 to 40,000 people, that's atypical pediatric or adult vaccine trial. So it wasn't, it was, the reason it happened so quickly was that the government took the risk out of it for the companies. I mean, we made a rotavirus vaccine in 26 years.

And I think that the size of those trials, 30,000 to 40,000 people, that's atypical pediatric or adult vaccine trial. So it wasn't, it was, the reason it happened so quickly was that the government took the risk out of it for the companies. I mean, we made a rotavirus vaccine in 26 years.

I think if the government had completely paid for everything and taken the risk out of it for all the companies, it would have been a lot faster.

I think if the government had completely paid for everything and taken the risk out of it for all the companies, it would have been a lot faster.